Right now, the HALT Study is underway to provide the substantial evidence of effectiveness necessary for the full FDA approval of Felycin-CA1 (referred to as TRIV202 in HALT) for the management of ...

Hypertrophic obstructive cardiomyopathy (HOCM or HCM) is a rare, usually inherited condition in which children develop too much muscle in the left chamber of the heart, the one which pumps blood ...

This is what recently happened to Sphynx cat, Marshall, when a vet visit revealed the unthinkable: a terminal heart condition ...

Background Patients with hypertrophic cardiomyopathy (HCM) often reduce their physical activity due to concerns about sudden cardiac death. However, objective data on activity patterns in HCM, ...

The presentation will cover data from dose cohorts 1 and 2 of the trial, which is evaluating TN-201, a gene replacement therapy for myosin-binding protein C3-associated hypertrophic cardiomyopathy.

The following slide deck was published by HUTCHMED (China) Limited in conjunction with this event.

Background: Massive left ventricular hypertrophy (mLVH) is a risk factor for sudden cardiac death (SCD) in children with hypertrophic cardiomyopathy (HCM). However, little else is understood about ...

Introduction: Diastolic dysfunction is a hallmark of heart failure with preserved ejection fraction, yet echocardiographic grading is challenging in patients with hypertrophic or amyloid ...

In a detailed post shared on X, cardiologist Dr. Shailesh Singh addressed a startling reality—that even individuals who appear to be in top physical shape, working out regularly and maintaining ...

Abstract: This paper presents an innovative methodology for applying signal processing techniques and machine learning to process recently available data for heart murmur detection and classification.